tert-Butyl-4-(isoquinolin-5-yl)piperazine-1-carboxylate, 97%, 100mg

6,7-Dihydro-5H-quinolin-8-one, 96.0%, 10g

Plan fase 20x/0,40 objetivo corregido al infinito

5-Cyclopropyl-2-ethynylpyridine, 98%, 100mg

1,6-Dihydroxynaphthalene>99.0%(GC)500g

2-(3-Bromo-5-isobutoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

8-Bromo-6-chloro-2-cyclopropylimidazo[1,2-b]pyridazine, 97%, 100mg

9-n-Octyl-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazole>97.0%(HPLC)(N)200mg

2,6-Dichloro-4-methylnicotinamide, 95.0%, 10g

(2-Morpholinophenyl)boronic acid, 95.0%, 5g

tert-Butyl2-(azetidin-3-yl)acetatehydrochloride, 98%, 250mg

5-(2,6-Difluoro-4-methoxyphenyl)oxazole, 98%, 500mg

tert-Butyl (3-(bromomethyl)-4-fluorophenyl)carbamate, 97%, 10g